Pharma Stock Roundup: JNJ's Q4 Earnings, FDA Nod to AZN, Daiichi Drug

Published on 24 Jan 2025 on Zacks · via Yahoo Finance

Novo Nordisk declined the most (36.6%). (See the last pharma stock roundup here: Pharma Stock...

Read the rest of the article

Start tracking your investments with Statfolio

Novo Nordisk declined the most (36.6%). (See the last pharma stock roundup here: Pharma Stock...

Zacks · via Yahoo Finance 24 Jan 2025

Sanofi (SNY) has received EU regulatory approval for its drug Sarclisa for the treatment of newly...

Seeking Alpha 22 Jan 2025

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article...

Insider Monkey · via Yahoo Finance 22 Jan 2025

The U.S. Food and Drug Administration (FDA) issued a warning letter to Sanofi SA’s SNY Genzyme Co...

Benzinga 22 Jan 2025

Maze Therapeutics and Metsera filed to list their stocks earlier in January. Like those two...

FierceBiotech 21 Jan 2025

The new coverage comes after a period of instability for the company, which included a contentiou...

Investing.com 21 Jan 2025

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In thi...

Insider Monkey · via Yahoo Finance 21 Jan 2025

Everything touching artificial intelligence (AI) is hot right now, so it's no surprise that the b...

Motley Fool · via Yahoo Finance 17 Jan 2025

Verona Pharma stock jumped 10.6% that day. During an investor breakfast, company executives were...

Investor's Business Daily 16 Jan 2025

We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 16 Jan 2025